|
US20050020945A1
(en)
*
|
2002-07-02 |
2005-01-27 |
Tosaya Carol A. |
Acoustically-aided cerebrospinal-fluid manipulation for neurodegenerative disease therapy
|
|
US20040049134A1
(en)
*
|
2002-07-02 |
2004-03-11 |
Tosaya Carol A. |
System and methods for treatment of alzheimer's and other deposition-related disorders of the brain
|
|
US8353853B1
(en)
*
|
2003-01-24 |
2013-01-15 |
Boston Scientific Scimed, Inc. |
Encephalic insonication
|
|
US7485706B2
(en)
*
|
2003-07-30 |
2009-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Neurodegenerative protein aggregation inhibition methods and compounds
|
|
US20050074506A1
(en)
*
|
2003-10-02 |
2005-04-07 |
Brainsgate Ltd. |
Targeted release of nitric oxide in the CNS circulation for modulating the BBB and treating disorders
|
|
US7896821B1
(en)
*
|
2003-11-14 |
2011-03-01 |
Perfusion Technology, LLC |
Low intensity directed ultrasound (LODUS) mediated blood brain barrier disruption
|
|
US7641660B2
(en)
*
|
2004-03-08 |
2010-01-05 |
Biomet Manufacturing Corporation |
Method, apparatus, and system for image guided bone cutting
|
|
WO2006044997A2
(en)
*
|
2004-10-15 |
2006-04-27 |
The Trustees Of Columbia University In The City Of New York |
System and method for localized measurement and imaging of viscosity of tissues
|
|
WO2006044996A2
(en)
*
|
2004-10-15 |
2006-04-27 |
The Trustees Of Columbia University In The City Of New York |
System and method for automated boundary detection of body structures
|
|
US7674229B2
(en)
*
|
2005-03-07 |
2010-03-09 |
The Brigham And Women's Hospital, Inc. |
Adaptive ultrasound delivery system
|
|
WO2006124603A2
(en)
*
|
2005-05-12 |
2006-11-23 |
The Trustees Of Columbia University In The City Of New York |
System and method for electromechanical wave imaging of body structures
|
|
US10687785B2
(en)
|
2005-05-12 |
2020-06-23 |
The Trustees Of Columbia Univeristy In The City Of New York |
System and method for electromechanical activation of arrhythmias
|
|
US20070016040A1
(en)
*
|
2005-06-24 |
2007-01-18 |
Henry Nita |
Methods and apparatus for intracranial ultrasound delivery
|
|
WO2007035721A2
(en)
*
|
2005-09-19 |
2007-03-29 |
The Trustees Of Columbia University In The City Of New York |
Ultrasound method to open blood brain barrier
|
|
WO2007067987A2
(en)
*
|
2005-12-09 |
2007-06-14 |
The Trustees Of Columbia University In The City Ofnew York |
Systems and methods for elastography imaging
|
|
EP1973948B1
(en)
|
2005-12-15 |
2015-02-11 |
Genentech, Inc. |
Methods and compositions for targeting polyubiquitin
|
|
AU2007247969A1
(en)
|
2006-05-04 |
2007-11-15 |
Genentech, Inc. |
Methods and compositions relating to ZPA polypeptides
|
|
CA2657681C
(en)
|
2006-07-14 |
2019-03-19 |
Ac Immune S.A. |
Humanized antibodies against beta amyloid protein
|
|
NZ607881A
(en)
|
2006-07-14 |
2014-11-28 |
Genentech Inc |
Humanized antibody against amyloid beta
|
|
US8150128B2
(en)
*
|
2006-08-30 |
2012-04-03 |
The Trustees Of Columbia University In The City Of New York |
Systems and method for composite elastography and wave imaging
|
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
|
JP2010530744A
(en)
|
2007-06-12 |
2010-09-16 |
エーシー イミューン ソシエテ アノニム |
Humanized antibody against amyloid β
|
|
AR066987A1
(en)
|
2007-06-12 |
2009-09-23 |
Ac Immune Sa |
MONOCLONAL ANTIBODY AGAINST BETA-AMYLIDE PROTEIN
|
|
SG178809A1
(en)
|
2007-10-05 |
2012-03-29 |
Genentech Inc |
Use of anti-amyloid beta antibody in ocular diseases
|
|
AU2008309520A1
(en)
*
|
2007-10-12 |
2009-04-16 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin |
Method for opening tight junctions
|
|
AR069501A1
(en)
|
2007-11-30 |
2010-01-27 |
Genentech Inc |
ANTI-VEGF ANTIBODIES (VASCULAR ENDOTELIAL GROWTH FACTOR)
|
|
WO2011035312A1
(en)
*
|
2009-09-21 |
2011-03-24 |
The Trustees Of Culumbia University In The City Of New York |
Systems and methods for opening of a tissue barrier
|
|
EP2318832B1
(en)
|
2008-07-15 |
2013-10-09 |
Academia Sinica |
Glycan arrays on ptfe-like aluminum coated glass slides and related methods
|
|
WO2010014977A1
(en)
|
2008-08-01 |
2010-02-04 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for matching and imaging tissue characteristics
|
|
WO2010030819A1
(en)
|
2008-09-10 |
2010-03-18 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for opening a tissue
|
|
EP3524620A1
(en)
|
2008-10-14 |
2019-08-14 |
Genentech, Inc. |
Immunoglobulin variants and uses thereof
|
|
AU2009308293B2
(en)
|
2008-10-22 |
2015-02-05 |
Genentech, Inc. |
Modulation of axon degeneration
|
|
JP6039183B2
(en)
|
2008-12-23 |
2016-12-07 |
ジェネンテック， インコーポレイテッド |
Immunoglobulin variants with altered binding to protein A
|
|
JP5887270B2
(en)
|
2009-09-02 |
2016-03-16 |
ジェネンテック， インコーポレイテッド |
Mutant SMOOTHENED AND METHOD OF USING THE SAME
|
|
US20160059044A1
(en)
|
2009-10-12 |
2016-03-03 |
Kona Medical, Inc. |
Energy delivery to intraparenchymal regions of the kidney to treat hypertension
|
|
US11998266B2
(en)
|
2009-10-12 |
2024-06-04 |
Otsuka Medical Devices Co., Ltd |
Intravascular energy delivery
|
|
US8469904B2
(en)
|
2009-10-12 |
2013-06-25 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
|
US8986231B2
(en)
|
2009-10-12 |
2015-03-24 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
|
US9119951B2
(en)
|
2009-10-12 |
2015-09-01 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
|
US8295912B2
(en)
|
2009-10-12 |
2012-10-23 |
Kona Medical, Inc. |
Method and system to inhibit a function of a nerve traveling with an artery
|
|
US8517962B2
(en)
|
2009-10-12 |
2013-08-27 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
|
US20110118600A1
(en)
*
|
2009-11-16 |
2011-05-19 |
Michael Gertner |
External Autonomic Modulation
|
|
US20110092880A1
(en)
*
|
2009-10-12 |
2011-04-21 |
Michael Gertner |
Energetic modulation of nerves
|
|
US8986211B2
(en)
|
2009-10-12 |
2015-03-24 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
|
US9174065B2
(en)
|
2009-10-12 |
2015-11-03 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
|
JP2013508401A
(en)
|
2009-10-22 |
2013-03-07 |
ジェネンテック， インコーポレイテッド |
Regulation of axonal degeneration
|
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
|
AR078377A1
(en)
|
2009-12-11 |
2011-11-02 |
Genentech Inc |
ANTI-VEGF-C ANTIBODIES (ISOLATED ANTI-VASCULAR ENDOTELIAL GROWTH FACTOR C) AND ITS METHODS OF USE
|
|
EP2516465B1
(en)
|
2009-12-23 |
2016-05-18 |
F.Hoffmann-La Roche Ag |
Anti-bv8 antibodies and uses thereof
|
|
US10338069B2
(en)
|
2010-04-12 |
2019-07-02 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
|
AU2011250970B2
(en)
|
2010-05-10 |
2016-12-15 |
Sinica, Academia |
Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
|
|
JP6081356B2
(en)
|
2010-07-30 |
2017-02-15 |
エーシー イミューン エス．エー． |
Safe and functional humanized anti-β-amyloid antibody
|
|
EP3527220A1
(en)
|
2010-08-12 |
2019-08-21 |
AC Immune S.A. |
Vaccine engineering
|
|
DK2625197T3
(en)
|
2010-10-05 |
2016-10-03 |
Genentech Inc |
Smoothened MUTANT AND METHODS OF USING THE SAME
|
|
ES2548686T3
(en)
|
2010-10-07 |
2015-10-20 |
Ac Immune S.A. |
Antibodies that recognize phospho-Tau
|
|
US9687447B2
(en)
|
2010-10-26 |
2017-06-27 |
Ac Immune S.A. |
Method for preparing liposome-based constructs
|
|
SG190682A1
(en)
|
2010-11-10 |
2013-07-31 |
Genentech Inc |
Methods and compositions for neural disease immunotherapy
|
|
US9320491B2
(en)
|
2011-04-18 |
2016-04-26 |
The Trustees Of Columbia University In The City Of New York |
Ultrasound devices methods and systems
|
|
WO2012162664A1
(en)
|
2011-05-26 |
2012-11-29 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for opening of a tissue barrier in primates
|
|
US9540434B2
(en)
|
2011-10-07 |
2017-01-10 |
Ac Immune S.A. |
Phosphospecific antibodies recognising tau
|
|
EP2766028B1
(en)
|
2011-10-14 |
2017-08-16 |
F. Hoffmann-La Roche AG |
Peptide inhibitors of bace1
|
|
WO2013071119A2
(en)
|
2011-11-10 |
2013-05-16 |
Genentech, Inc |
Methods for treating, diagnosing and monitoring alzheimer's disease
|
|
MX356800B
(en)
|
2012-04-05 |
2018-06-13 |
Ac Immune Sa |
Humanized tau antibody.
|
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
|
CN104271566B
(en)
|
2012-05-22 |
2017-05-31 |
霍夫曼-拉罗奇有限公司 |
Substituted bipyridyl amine and application thereof
|
|
SG11201408284VA
(en)
|
2012-05-22 |
2015-02-27 |
Xenon Pharmaceuticals Inc |
N-substituted benzamides and their use in the treatment of pain
|
|
EP2870138B1
(en)
|
2012-07-06 |
2018-08-22 |
Genentech, Inc. |
N-substituted benzamides and methods of use thereof
|
|
US9914956B2
(en)
|
2012-08-18 |
2018-03-13 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
|
AU2013305827A1
(en)
|
2012-08-21 |
2015-03-05 |
Academia Sinica |
Benzocyclooctyne compounds and uses thereof
|
|
GB2505740A
(en)
*
|
2012-09-05 |
2014-03-12 |
Surf Technology As |
Instrument and method for ultrasound mediated drug delivery
|
|
CA2885908A1
(en)
|
2012-09-27 |
2014-04-03 |
F. Hoffmann-La Roche Ag |
Substituted sulfonamide compounds
|
|
WO2014059170A1
(en)
|
2012-10-10 |
2014-04-17 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for mechanical mapping of cardiac rhythm
|
|
AU2013204200B2
(en)
|
2012-10-11 |
2016-10-20 |
Brandeis University |
Treatment of amyotrophic lateral sclerosis
|
|
DE102012222778A1
(en)
*
|
2012-12-11 |
2014-06-12 |
Siemens Aktiengesellschaft |
Intravascular ultrasound source for reversible overcoming of blood-brain barrier in e.g. human, has catheter to move source through blood vessel to place within skull of human or animal, so as to locally overcome blood-brain barrier
|
|
MX2015009270A
(en)
|
2013-01-18 |
2015-10-30 |
Hoffmann La Roche |
3-substituted pyrazoles and use as dlk inhibitors.
|
|
EP2968280A4
(en)
|
2013-03-14 |
2016-08-10 |
Genentech Inc |
Substituted triazolopyridines and methods of use thereof
|
|
CN105143258B
(en)
|
2013-03-15 |
2020-06-23 |
Ac免疫有限公司 |
anti-Tau antibodies and methods of use
|
|
EA029568B8
(en)
|
2013-05-01 |
2018-08-31 |
Ф.Хоффманн-Ля Рош Аг |
Biheteroaryl compounds and uses thereof
|
|
EP2991977B1
(en)
|
2013-05-01 |
2020-07-22 |
F.Hoffmann-La Roche Ag |
C-linked heterocycloalkyl substituted pyrimidines and their uses
|
|
US9247921B2
(en)
|
2013-06-07 |
2016-02-02 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods of high frame rate streaming for treatment monitoring
|
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
|
US10322178B2
(en)
|
2013-08-09 |
2019-06-18 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for targeted drug delivery
|
|
US10028723B2
(en)
|
2013-09-03 |
2018-07-24 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods for real-time, transcranial monitoring of blood-brain barrier opening
|
|
US9782476B2
(en)
|
2013-09-06 |
2017-10-10 |
Academia Sinica |
Human iNKT cell activation using glycolipids with altered glycosyl groups
|
|
HUE041652T2
(en)
|
2013-10-11 |
2019-05-28 |
Hoffmann La Roche |
Substituted heterocyclic sulfonamide compounds useful as trpa1 modulators
|
|
MX2016008110A
(en)
|
2013-12-20 |
2016-08-19 |
Hoffmann La Roche |
Pyrazole derivatives and uses thereof as inhibitors of dlk.
|
|
KR20160104727A
(en)
|
2014-01-16 |
2016-09-05 |
아카데미아 시니카 |
Compositions and methods for treatment and detection of cancers
|
|
WO2016114819A1
(en)
|
2015-01-16 |
2016-07-21 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
JP6736467B2
(en)
|
2014-02-04 |
2020-08-05 |
ジェネンテック， インコーポレイテッド |
Smoothing mutant and method of using the same
|
|
EP3129767B1
(en)
|
2014-03-27 |
2021-09-01 |
Academia Sinica |
Reactive labelling compounds and uses thereof
|
|
US10478120B2
(en)
|
2014-05-17 |
2019-11-19 |
The Johns Hopkins University |
MRI-guided intraarterial catheter-based method for predicting territory of local blood brain barrier opening
|
|
KR20170005142A
(en)
|
2014-05-27 |
2017-01-11 |
아카데미아 시니카 |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
|
EP3149036A4
(en)
|
2014-05-27 |
2017-12-27 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
|
EP3149037A4
(en)
|
2014-05-27 |
2018-01-10 |
Academia Sinica |
Anti-her2 glycoantibodies and uses thereof
|
|
JP7063538B2
(en)
|
2014-05-28 |
2022-05-09 |
アカデミア シニカ |
Anti-TNFα sugar-manipulated antibody group and its use
|
|
WO2015192189A1
(en)
*
|
2014-06-20 |
2015-12-23 |
The University Of Queensland |
Neurodegenerative disease treatment
|
|
EP3166939B1
(en)
|
2014-07-07 |
2019-06-05 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
TWI745275B
(en)
|
2014-09-08 |
2021-11-11 |
中央研究院 |
HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
|
|
US10925579B2
(en)
|
2014-11-05 |
2021-02-23 |
Otsuka Medical Devices Co., Ltd. |
Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery
|
|
JP6859259B2
(en)
|
2014-11-19 |
2021-04-14 |
ジェネンテック， インコーポレイテッド |
Antibodies to BACEl and its use for neurological disease immunotherapy
|
|
CA2966964A1
(en)
|
2014-11-19 |
2016-05-26 |
Michal Novak |
Humanized tau antibodies in alzheimer's disease
|
|
CN107864633A
(en)
|
2014-12-19 |
2018-03-30 |
皮埃尔与玛丽·居里-巴黎第六大学 |
Implantable ultrasound for brain treatment occurs the equipment of therapeutic system including this device and implements the method for this device
|
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
|
WO2016118961A1
(en)
|
2015-01-24 |
2016-07-28 |
Academia Sinica |
Cancer markers and methods of use thereof
|
|
AU2015378564A1
(en)
|
2015-01-24 |
2017-07-13 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
|
EP3250590B1
(en)
|
2015-01-30 |
2021-09-15 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced anti-ssea4 antibody efficacy
|
|
CA2975875A1
(en)
|
2015-02-04 |
2016-08-11 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
|
EP3268373B1
(en)
|
2015-03-09 |
2022-04-27 |
F. Hoffmann-La Roche AG |
Tricyclic dlk inhibitors and uses thereof
|
|
WO2016191312A1
(en)
|
2015-05-22 |
2016-12-01 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
JP2018526371A
(en)
|
2015-08-27 |
2018-09-13 |
ジェネンテック， インコーポレイテッド |
Therapeutic compounds and methods of use thereof
|
|
CN108350605A
(en)
|
2015-09-04 |
2018-07-31 |
台湾浩鼎生技股份有限公司 |
Glycan array and application method
|
|
WO2017091592A1
(en)
|
2015-11-25 |
2017-06-01 |
Genentech, Inc. |
Substituted benzamides useful as sodium channel blockers
|
|
CN109071625A
(en)
|
2016-02-04 |
2018-12-21 |
柯瑞斯公司 |
Smooth mutant and its application method
|
|
CA3016170A1
(en)
|
2016-03-08 |
2017-09-14 |
Academia Sinica |
Methods for modular synthesis of n-glycans and arrays thereof
|
|
WO2017153799A1
(en)
|
2016-03-11 |
2017-09-14 |
Universite Pierre Et Marie Curie (Paris 6) |
External ultrasound generating treating device for spinal cord and spinal nerves treatment, apparatus comprising such device and method implementing such device
|
|
WO2017153798A1
(en)
|
2016-03-11 |
2017-09-14 |
Université Pierre Et Marie Curie (Paris 6) |
Implantable ultrasound generating treating device for spinal cord and/or spinal nerve treatment, apparatus comprising such device and method
|
|
US10980894B2
(en)
|
2016-03-29 |
2021-04-20 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
|
AU2017239637A1
(en)
|
2016-03-29 |
2018-11-15 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
|
EP3854782A1
(en)
|
2016-03-30 |
2021-07-28 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
BR112018071683A2
(en)
|
2016-04-22 |
2019-02-19 |
Obi Pharma, Inc. |
method for treating breast cancer, method for treating a tumor in a patient, method for treating an individual suffering from cancer by immunotherapy, method for inducing / improving an immune response in an individual, method for improving obi-822 induced vaccine by immune response in an individual in need thereof, method for identifying a patient suitable for cancer therapy, and method for determining a patient's cancer treatment prognosis or drug response
|
|
EP3487853B1
(en)
|
2016-07-20 |
2022-06-08 |
F. Hoffmann-La Roche AG |
Bicyclic proline compounds
|
|
JP6975515B2
(en)
|
2016-07-20 |
2021-12-01 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Sulfonylcycloalkylcarboxamide compounds as TRPA1 modulators
|
|
WO2018022933A1
(en)
|
2016-07-27 |
2018-02-01 |
Obi Pharma, Inc. |
Immunogenic/therapeutic glycan compositions and uses thereof
|
|
US11643456B2
(en)
|
2016-07-29 |
2023-05-09 |
Obi Pharma, Inc. |
Human antibodies, pharmaceutical compositions and methods
|
|
EP3497093B1
(en)
|
2016-08-12 |
2021-09-15 |
F. Hoffmann-La Roche AG |
Sulfonyl pyridyl trp inhibitors
|
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
|
CN109843886B
(en)
|
2016-10-17 |
2022-04-19 |
豪夫迈·罗氏有限公司 |
Bicyclic pyridone lactams and methods of use thereof
|
|
WO2018094414A1
(en)
|
2016-11-21 |
2018-05-24 |
Obi Pharma, Inc. |
Conjugated biological molecules, pharmaceutical compositions and methods
|
|
EP3544979B1
(en)
|
2016-11-28 |
2021-08-04 |
F. Hoffmann-La Roche AG |
Oxadiazolones as transient receptor potential channel inhibitors
|
|
CN110023313B
(en)
|
2016-12-02 |
2022-10-25 |
豪夫迈·罗氏有限公司 |
Bicyclic amide compounds and methods of use thereof
|
|
US11072607B2
(en)
|
2016-12-16 |
2021-07-27 |
Genentech, Inc. |
Inhibitors of RIP1 kinase and methods of use thereof
|
|
CN110461838B
(en)
|
2017-03-07 |
2022-05-06 |
豪夫迈·罗氏有限公司 |
Oxadiazole transient receptor potential channel inhibitors
|
|
JP2020511511A
(en)
|
2017-03-24 |
2020-04-16 |
ジェネンテック， インコーポレイテッド |
4-Piperidin-N- (pyrimidin-4-yl) chroman-7-sulfonamide derivatives as sodium channel inhibitors
|
|
RS65308B1
(en)
|
2017-07-14 |
2024-04-30 |
Hoffmann La Roche |
Bicyclic ketone compounds and methods of use thereof
|
|
EP3460057A1
(en)
|
2017-09-22 |
2019-03-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Kdac variants and uses thereof
|
|
MX2020003439A
(en)
|
2017-10-11 |
2020-07-29 |
Hoffmann La Roche |
Bicyclic compounds for use as rip1 kinase inhibitors.
|
|
SG11202002877RA
(en)
|
2017-10-31 |
2020-04-29 |
Hoffmann La Roche |
Bicyclic sulfones and sulfoxides and methods of use thereof
|
|
BR112020010903A2
(en)
|
2017-11-30 |
2020-11-17 |
Hanmi Pharm. Co., Ltd. |
compound, salt of a compound of formula (I), pharmaceutical composition, use of a pharmaceutical composition, use of a compound, method of preparing a crystalline form of the salt
|
|
AR114585A1
(en)
|
2018-02-20 |
2020-09-23 |
Hoffmann La Roche |
PROCESS FOR PREPARING ANTAGONIST COMPOUNDS OF POTENTIAL TRANSIENT CHANNELS OF THE 1-ARYLSULFONYL-PYRROLIDIN-2-CARBOXAMIDE RECEPTOR AND CRYSTALLINE FORMS THEREOF
|
|
TW202000651A
(en)
|
2018-02-26 |
2020-01-01 |
美商建南德克公司 |
Therapeutic compounds and methods of use thereof
|
|
US10710994B2
(en)
|
2018-03-19 |
2020-07-14 |
Genentech, Inc. |
Oxadiazole transient receptor potential channel inhibitors
|
|
MX2020009991A
(en)
|
2018-03-28 |
2020-10-14 |
Axon Neuroscience Se |
Antibody-based methods of detecting and treating alzheimer's disease.
|
|
US10947251B2
(en)
|
2018-03-30 |
2021-03-16 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
EP3781571B1
(en)
|
2018-04-20 |
2024-01-17 |
F. Hoffmann-La Roche AG |
N-[4-oxo-2,3-dihydro-pyrido[3,2-b][1,4]oxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs)
|
|
TW202003490A
(en)
|
2018-05-22 |
2020-01-16 |
瑞士商赫孚孟拉羅股份公司 |
Therapeutic compounds and methods of use thereof
|
|
TW202035444A
(en)
|
2018-06-27 |
2020-10-01 |
台灣浩鼎生技股份有限公司 |
Glycosynthase variants for glycoprotein engineering and methods of use
|
|
WO2020051099A1
(en)
|
2018-09-03 |
2020-03-12 |
Genentech, Inc. |
Carboxamide and sulfonamide derivatives useful as tead modulators
|
|
US20200108241A1
(en)
*
|
2018-10-04 |
2020-04-09 |
Synaptec Network, Inc. |
Systems and Methods for Delivering Exosomes Through the Blood-Brain Barrier
|
|
US11554267B2
(en)
|
2018-10-05 |
2023-01-17 |
Synaptec Network, Inc. |
Systems and methods for delivering therapeutic agents to the brain using TMS
|
|
AU2018446059A1
(en)
*
|
2018-10-17 |
2021-05-20 |
The University Of Queensland |
Methods and compositions for treating tauopathies
|
|
CN113302193A
(en)
|
2019-01-11 |
2021-08-24 |
豪夫迈·罗氏有限公司 |
Bicyclic pyrrolotriazolone compounds and methods of use thereof
|
|
JP7474773B2
(en)
|
2019-02-13 |
2024-04-25 |
アルフェウス メディカル，インク． |
Non-invasive sonodynamic therapy
|
|
KR20220101138A
(en)
|
2019-11-13 |
2022-07-19 |
제넨테크, 인크. |
Therapeutic compounds and methods of use
|
|
CN115151562A
(en)
|
2019-12-04 |
2022-10-04 |
Ac免疫有限公司 |
Novel molecules for therapy and diagnosis
|
|
US11787775B2
(en)
|
2020-07-24 |
2023-10-17 |
Genentech, Inc. |
Therapeutic compounds and methods of use
|
|
CN116615452A
(en)
|
2020-08-14 |
2023-08-18 |
Ac免疫有限公司 |
Humanized anti-TDP-43 binding molecules and uses thereof
|
|
KR20230079123A
(en)
|
2020-10-02 |
2023-06-05 |
제넨테크, 인크. |
Nonheteroaryl Compounds and Processes for the Preparation of Their Crystalline Forms
|
|
EP4229082A1
(en)
|
2020-10-16 |
2023-08-23 |
AC Immune SA |
Antibodies binding to alpha-synuclein for therapy and diagnosis
|
|
WO2022265611A1
(en)
*
|
2021-06-17 |
2022-12-22 |
Aselsan Elektroni̇k Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
An arrangement for vaporizing nanoagents suitable for therapy inside the human body and a device comprising this arrangement
|
|
WO2023028056A1
(en)
|
2021-08-24 |
2023-03-02 |
Genentech, Inc. |
3-amino piperidyl sodium channel inhibitors
|
|
WO2023028077A1
(en)
|
2021-08-24 |
2023-03-02 |
Genentech, Inc. |
Sodium channel inhibitors and methods of designing same
|
|
US20230203062A1
(en)
|
2021-11-24 |
2023-06-29 |
Genentech, Inc. |
Therapeutic compounds and methods of use
|
|
TW202332429A
(en)
|
2021-11-24 |
2023-08-16 |
美商建南德克公司 |
Therapeutic compounds and methods of use
|
|
WO2023156549A1
(en)
|
2022-02-16 |
2023-08-24 |
Ac Immune Sa |
Humanized anti-tdp-43 binding molecules and uses thereof
|
|
WO2023194565A1
(en)
|
2022-04-08 |
2023-10-12 |
Ac Immune Sa |
Anti-tdp-43 binding molecules
|
|
WO2024079662A1
(en)
|
2022-10-11 |
2024-04-18 |
Meiragtx Uk Ii Limited |
Upf1 expression constructs
|